We serve Chemical Name:mercuric arsenate CAS:7784-37-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:mercuric arsenate
CAS.NO:7784-37-4
Synonyms:Mercuric arsenate;Mercury(II) o-arsenate;UN1623;Mercuric arsenate [UN1623] [Poison];EINECS 232-062-1;Arsenic acid (H3AsO4),mercury(2+) salt (1:1);Mercury hydrogenarsenate
Molecular Formula:AsHHgO4
Molecular Weight:340.51700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:83.42000
Exact Mass:341.88000
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1623
Packing Group:II
Contact us for information like Mercuric arsenate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Mercury hydrogenarsenate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Mercuric arsenate [UN1623] [Poison] Use and application,Mercury hydrogenarsenate technical grade,usp/ep/jp grade.
Related News: “The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. 5-methyl-4-(thiazol-2-yldiazenyl)benzene-1,3-diol manufacturers “The most important thing to be considered while determining a CDMO competency is their technical knowledge along with adequate expertise to accomplish the drug development till commercial scaling. N-[1′-(3-Cyano-3,3-diphenyl-propyl)-[1,4′]bipiperidinyl-4′-ylmethyl]-acetamide suppliers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. 2-oxo-5-phenyl-1H-pyrazine-3-carboxamide vendor & factory According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, ,Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug.
